Relationship Between Plasma P‐Tau‐217 And Amyloid PET In Racial And Ethnic Underrepresented Groups (RE‐URG) Compared With Non‐RE‐URG In LEARN And A4
Doris P. Molina‐Henry, Oliver Langford, Michael C. Donohue, Rema Raman, Roy Yaari, John R. Sims, Karen Chilcott Holdridge, Paul S. S. Aisen, Keith A Johnson, Robert A. Rissman, Reisa A Sperling, The A4 Study Team · 2025
Read Relationship Between Plasma P‐Tau‐217 And Amyloid PET In Racial And Ethnic Underrepresented Groups (RE‐URG) Compared With Non‐RE‐URG In LEARN And A4 by Doris P. Molina‐Henry, Oliver Langford, Michael C. Donohue, Rema Raman, Roy Yaari, John R. Sims, Karen Chilcott Holdridge, Paul S. S. Aisen, Keith A Johnson, Robert A. Rissman, Reisa A Sperling, The A4 Study Team (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11716513.txt.
Description
Doris Molina-Henry and co-authors check whether a blood test for Alzheimer's pathology reads the same across racial and ethnic groups. The marker, plasma p-tau217, predicts amyloid buildup on brain scans, but trial data skew toward majority groups. They pooled two preclinical studies with nearly a thousand unimpaired adults, about a hundred from underrepresented groups.
The link between the blood marker and scan values matched across groups. A genetic risk factor did not bend the link in either group. The authors call for bigger samples per subgroup to confirm that the marker travels well.
Catalog record
| CREATOR | Doris P. Molina‐Henry, Oliver Langford, Michael C. Donohue, Rema Raman, Roy Yaari, John R. Sims, Karen Chilcott Holdridge, Paul S. S. Aisen, Keith A Johnson, Robert A. Rissman, Reisa A Sperling, The A4 Study Team |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |